CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 95 filers reported holding CYTOSORBENTS CORP in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $420,000 | +677.8% | 131,655 | +912.5% | 0.06% | +700.0% |
| Q4 2021 | $54,000 | -90.8% | 13,003 | -82.9% | 0.01% | -95.2% |
| Q1 2020 | $586,000 | +134.4% | 75,869 | +16.8% | 0.15% | +406.9% |
| Q4 2019 | $250,000 | +51.5% | 64,970 | +98.0% | 0.03% | +31.8% |
| Q3 2019 | $165,000 | +28.9% | 32,820 | +94.4% | 0.02% | +69.2% |
| Q1 2019 | $128,000 | – | 16,882 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
| Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
| Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
| One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
| Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
| Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
| Avenir Corp | 150,600 | $580,000 | 0.06% |
| HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
| Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |